ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Cancer Care Act Introduced In Senate.

April 18, 2008

Shubik Group Finally Completes Document On Carcinogenicity Criteria

March 12, 1976

“Roller-Coaster Budget” For NIH Criticized On Capitol Hill; $1 Billion Cut By FY 2000?

March 17, 1995

Partnership Points to New Path Forward For Drug Approval and Clinical Research

June 20, 2014

In Brief: John Mendelson To Succeed LaMaistre As President, M.D Anderson Cancer Center

May 17, 1996

DCT Concepts Approved

October 11, 1985